Koshinski Asset Management, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History
Koshinski Asset Management, Inc.
- $1.49 Trillion
- Q3 2025
A detailed history of Koshinski Asset Management, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Koshinski Asset Management, Inc. holds 6,749 shares of ARWR stock, worth $277,653. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,749Holding current value
$277,653% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
340Shares Held
99.4MCall Options Held
368KPut Options Held
520K-
Vanguard Group Inc Valley Forge, PA16MShares$660 Million0.01% of portfolio
-
Black Rock Inc. New York, NY15.7MShares$645 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.9MShares$448 Million5.14% of portfolio
-
State Street Corp Boston, MA6.4MShares$263 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$215 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.35B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...